← Back to Search

Smart Discharges for Improving Child Health Post-Discharge

N/A
Recruiting
Led By Matthew O Wiens, PharmD, PhD
Research Sponsored by University of British Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from discharge until 6 months post-discharge
Awards & highlights

Study Summary

This trial seeks to reduce childhood mortality in Uganda by predicting risk of recurrent illness and providing post-discharge support.

Who is the study for?
This trial is for children under five who were hospitalized with a suspected or proven infection in Uganda. Parents must consent to participate. Children directly admitted after birth, previously enrolled, outside the hospital area, with language barriers, or whose parents refuse cannot join.Check my eligibility
What is being tested?
The study tests 'Smart Discharges,' which involves predicting a child's risk of illness after leaving the hospital and providing extra care post-discharge to reduce mortality and improve health-seeking behavior among at-risk children.See study design
What are the potential side effects?
Since this intervention focuses on discharge planning and follow-up rather than medication or medical procedures, traditional side effects are not applicable. However, there may be impacts on family routines or stress levels due to increased monitoring.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from discharge until 6 months post-discharge
This trial's timeline: 3 weeks for screening, Varies for treatment, and from discharge until 6 months post-discharge for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Post-discharge mortality
Secondary outcome measures
Post-discharge health seeking
Post-discharge re-admission

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Phase 2: Interventional, children 0-59 months of ageExperimental Treatment1 Intervention
Phase 2: Intervention
Group II: Phase 1: Observational, children 0-59 months of ageActive Control1 Intervention
Phase 1: Observational only

Find a Location

Who is running the clinical trial?

University of British ColumbiaLead Sponsor
1,413 Previous Clinical Trials
2,455,261 Total Patients Enrolled
12 Trials studying Sepsis
28,837 Patients Enrolled for Sepsis
WalimuOTHER
4 Previous Clinical Trials
80,702 Total Patients Enrolled
1 Trials studying Sepsis
60 Patients Enrolled for Sepsis
Mbarara University of Science and TechnologyOTHER
78 Previous Clinical Trials
64,341 Total Patients Enrolled

Media Library

Risk-stratified discharge and post-discharge care Clinical Trial Eligibility Overview. Trial Name: NCT05730452 — N/A
Sepsis Research Study Groups: Phase 2: Interventional, children 0-59 months of age, Phase 1: Observational, children 0-59 months of age
Sepsis Clinical Trial 2023: Risk-stratified discharge and post-discharge care Highlights & Side Effects. Trial Name: NCT05730452 — N/A
Risk-stratified discharge and post-discharge care 2023 Treatment Timeline for Medical Study. Trial Name: NCT05730452 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the sample population for this research limited to individuals aged 40 or older?

"We are looking for participants who range in age from 0 days to 59 months."

Answered by AI

Who qualifies to be a participant in this clinical investigation?

"This trial is recruiting 117 hundred participants with sepsis, aged between 0 days and 59 months old. To be considered eligible for the study, potential patients must meet these requirements."

Answered by AI

Are there any current opportunities to participate in this clinical experiment?

"According to the records on clinicaltrials.gov, this medical trial is currently open for recruitment and was initially posted in July of 2017, with its last update occurring in February of 2023."

Answered by AI

How many individuals are partaking in this investigation?

"Affirmative, clinicaltrials.gov data reveals that this experiment is currently enrolling patients. The trial was first posted on July 16th 2017 and recently updated on February 14th 2023. Over 11700 participants need to be recruited from 1 medical centre."

Answered by AI
~1510 spots leftby Apr 2025